Literature DB >> 6029492

The effects of triiodothyronine on hemodynamic responses to epinephrine and norepinephrine in man.

V S Aoki, W R Wilson, E O Theilen, W W Lukensmeyer, P E Leaverton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6029492

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  The clinical importance of the sympathetic nervous system in Graves' disease.

Authors:  D G McDevitt
Journal:  Ir J Med Sci       Date:  1977-11       Impact factor: 1.568

2.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Studies of isolated fetal mouse hearts in organ culture. Evidence for a direct effect of triiodothyronine in enhancing cardiac responsiveness to norepinephrine.

Authors:  K Wildenthal
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

5.  Influence of thyroid hormones on the sensitivity of cardiac and smooth muscle to biogenic amines and other drugs.

Authors:  P F Coville; J M Telford
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

6.  Catecholamine sensitivity in hyperthyroidism and hypothyroidism.

Authors:  D G McDevitt; J G Riddell; D R Hadden; D A Montgomery
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

7.  Effects of triiodothyronine-induced hypermetabolism on factor 8 and fibrinogen in man.

Authors:  J C Hoak; W R Wilson; E D Warner; E O Theilen; G L Fry; F L Benoit
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

8.  Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.

Authors:  K Tawara; K Kawashima; H Ishikawa; K Yamamoto; K Saito; A Ebihara; S Yoshida
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.